The development and status quo of pharmaceutical e commerce

The promotion of the pharmaceutical virtual market starts from the procurement of hospitals, so as to truly affect the mode of drug trading, so that the application of the pharmaceutical virtual market is deepened step by step.

Key features of pharmaceutical e-commerce:In view of China's national conditions, including the industrial structure of the pharmaceutical industry, the current situation of market-oriented construction, and the legal and regulatory environment, the development of pharmaceutical e-commerce in China has also shown its own characteristics compared with the developed countries in the world. These features include:

In general, the application of e-commerce is scattered, the level of development is not high, and the scale of the companies engaged in it is small.

In terms of application depth, it mainly stays at the level of information services, and there are few complete e-commerce services.

In terms of business model, the development of online pharmacies is restricted, and online wholesale business has become the mainstream of e-commerce applications.

With the continuous advancement of the "Healthy China" strategy, the "Internet + medical health" model represented by pharmaceutical e-commerce is becoming a new trend. In the past few months severely affected by the epidemic, pharmaceutical e-commerce has demonstrated the unique value of the Internet in terms of products, services and efficiency. So why can pharmaceutical e-commerce develop rapidly?

Let's take a look.

1. The outflow of prescriptions is another significant trend in the development of the pharmaceutical e-commerce industry. "Separation of medicine" can effectively break the dilemma of the current medical structure of "using medicine to support medicine", provide patients with more options for purchasing drugs, and at the same time, allow hospitals to focus on providing more elaborate and high-quality medical services. Under the new drug circulation system, e-commerce platforms will become more and more important in the future sales of prescription drugs.

2. With the outflow of prescriptions, medical insurance payment access has become one of the keys to a breakthrough in pharmaceutical e-commerce. After the prescription outflow and medical insurance settlement are fully connected, patients with chronic diseases can more easily achieve follow-up and repurchase, and for hospitals, online medical insurance payment can also shorten the billing period and reduce the pressure on cash flow, which is a win-win measure. At the same time, the electronic transaction of the whole process can also allow the regulator to more effectively supervise the use of medical insurance funds and promote the more efficient use of medical insurance funds.

3. The full-cycle management service of chronic diseases is another flashpoint for the development of pharmaceutical e-commerce in the future. The data shows that most patients with chronic diseases need long-term medication and regular follow-up, and there is a high demand for medical services. If the pharmaceutical e-commerce platform wants to serve it well, it must get rid of the positioning of a single drug sales platform to serve the full-cycle management of users' life and health.

Hello dear, happy to solve the problem for you, <>

The difference between pharmaceutical marketing and e-commerce and the connection A: Compared with the pharmacy major, the e-commerce major is better. E-commerce is an undergraduate major approved by the Ministry of Education in 2000, and it is an emerging major based on information technology such as the Internet and oriented to business activities in the modern economic and social fields.

E-commerce majors have a wide range of e-commerce majors and a high employment rate. After graduation, students majoring in e-commerce can be engaged in the design, bridge construction and promotion and network maintenance of enterprises and institutions; Can be engaged in online business activities, network marketing and planning, logistics management, etc., as well as engaged in e-commerce teaching at all levels of schools.

With the rapid development of e-commerce, products in various industries have begun to be sold online through the Internet, including the pharmaceutical industry. What do you need to know about pharmaceutical e-commerce? Let's take a look at it with the medicine elf.

1. Definition of pharmaceutical e-commerce: Pharmaceutical e-commerce, that is, pharmaceutical e-commerce, refers to the exchange of pharmaceutical products and the provision of related services by medical institutions, pharmaceutical companies, pharmaceutical manufacturers, medical information service providers, third-party institutions, etc. with modern information technology such as computer and network technology. From the definition, it can be seen that the main innovation of pharmaceutical e-commerce lies in the field of pharmaceutical circulation, and relying on the e-commerce model, pharmaceutical products can be transferred to end consumers and downstream distributors faster and more effectively.

2. The main characteristics of pharmaceutical e-commerce: First, the transaction process is completed in whole or in part in the network environment, but the transaction subject must pass the real-name authentication of an authoritative institution, and the drugs in the circulation link are mainly over-the-counter drugs. Second, both parties to the transaction must have the qualifications to meet the requirements of laws and regulations.

Third, the scope of transactions, transaction behaviors and methods must fully comply with the requirements of laws and regulations.

3. Pharmaceutical e-commerce modelAt present, the main modes of pharmaceutical e-commerce include retail B2C model, B2B model of wholesale transactions of pharmaceutical enterprises, 020 mode of online and offline cooperation, and third-party transaction service platform model.

Pharmaceutical e-commerce refers to the business model of drug sales and services through Internet channels, including the exchange of pharmaceutical products and the provision of related services through Internet channels by drug production or business enterprises and various service providers. In recent years, with the rapid growth of the pharmaceutical e-commerce market, the number of participants in the industry has gradually increased, and China's pharmaceutical e-commerce has ushered in rapid development.

The size of industry transactions is growing rapidly

According to the data released by the Network Economic Society, in 2019, the scale of China's pharmaceutical e-commerce transactions reached 100 million yuan, a year-on-year increase. Although the growth rate has slowed down from 2018, it is still at a high level. With the outbreak of the new crown epidemic in 2020, China's Internet medical service industry ushered in a new round of rapid growth.

The penetration rate of the industry is increasing year by year

According to the data released by the Network Economic Society, in recent years, the penetration rate of China's pharmaceutical e-commerce has increased year by year, and the penetration rate of China's pharmaceutical e-commerce industry in 2019 is expected to reach by 2020.

There are many participants in the industry 1. The activity of drug network users ranks first

The rapid development of the pharmaceutical e-commerce industry has made the platform types more perfect, and there are more and more industry participants. At present, there are three types of pharmaceutical e-commerce in China: B2B, B2C, and O2O, and there are many participants in each type of platform, and the situation of different types of mainstream platforms is as follows:

According to the data released by the Economic Society, the top 3 platforms for the number of active pharmaceutical e-commerce companies in China in 2019 are: 1 Yao.com, KangAiduo, and Jianke.com. From the perspective of the number of monthly active users, 1 drug network ranks first, with a monthly active number of 10,000, KangAiduo and Jianke.com are 10,000 and 10,000 respectively.

The scale of financing in the industry has increased

According to the data released by the Network Economic Agency, in 2019, a total of 6 financing events occurred in China's pharmaceutical e-commerce industry, with a financing amount of 100 million yuan, an increase compared with 2018, which shows that the investment and financing of the industry has picked up, and the industry has huge growth potential.

The above data and analysis are from the Prospective Industry Research InstituteAnalysis Report on China's Pharmaceutical Commercial Market Prospect and Investment Strategic Planning.

On March 9, 2020, iimedia Research, a world-renowned third-party data mining and analysis agency for the new economy industry, released the "2020-2021 China Medical E-commerce Industry Development Trend and Benchmarking Enterprise Analysis Report". The report analyzes the development of China's medical e-commerce industry in 2020 based on the basic data of iiMedia Data Center, iiMedia Consulting Business Intelligence Database, and iiMedia Business and Public Opinion Data Monitoring System. This report mainly focuses on the upstream and downstream operation mode of the medical e-commerce industry through the aspects of pharmaceutical e-commerce and household medical devices, and analyzes typical enterprises such as Yuyue Group, Ping An Good Doctor, and Aikangduo, so as to predict the development trend of China's medical e-commerce industry.

In 2019, the development scale of China's pharmaceutical e-commerce industry continued to increase, and many new retail methods emerged. More and more pharmaceutical companies are pouring into the B2B mainstream market, and the scale of the B2C market has also developed greatly with the improvement of consumers' health awareness and the fixation of online shopping habits. More and more pharmaceutical companies have also begun to carry out O2O business. The model of "medicine + medicine" development has also been widely recognized.

Especially under the influence of the new coronavirus pneumonia epidemic, medical e-commerce has played an important role in the fight against the epidemic with its unique Internet advantages. Under this opportunity, the medical e-commerce industry will usher in a period of historical opportunity for major popularization and development in 2020.

The driving force for the development of China's medical e-commerce industry in 2020: online shopping consumption

With the increase in Internet penetration, the number of online shopping users, online shopping penetration rate, and online shopping transaction amount in China have grown steadily every year. According to **, the number of online shopping users in China will reach 100 million in 2020, the penetration rate of online shopping will reach, and the transaction amount will reach one trillion yuan. As China's e-commerce market moves towards more mature and high-quality development, the medical e-commerce industry will also be further developed.

2020 China's medical e-commerce development driver: the increase in chronic disease patients

In 2018, there were more than 300 million people with chronic diseases in China, of which 60% were over 60 years old. Among all diseases, the group with hypertension accounts for the highest proportion (.

The total sales volume of China's pharmaceutical e-commerce direct reporting enterprises (excluding A certificates) has grown rapidly since 2015, and the total sales of China's pharmaceutical e-commerce direct reporting enterprises (excluding A certificates) exceeded 100 billion yuan in 2019. The sales volume of China's pharmaceutical e-commerce direct reporting enterprises (excluding A certificates) will maintain growth at an average annual compound growth rate of about 17%, and is expected to be close to 140 billion yuan in 2021.

3. With the rapid development of China's e-commerce, the in-depth combination of Internet + and various industries, the restrictions on online sales of drugs in China have gradually decreased, and China's pharmaceutical e-commerce has developed tremendously. In 2018, the scale of national pharmaceutical e-commerce (including third-party A certificates) reached 231.5 billion yuan, of which the scale of B2B business reached 93.1 billion yuan, maintaining an industry growth rate of more than 30%, and B2C business maintained stable development. In the future, China's online prescription drugs are expected to be lifted, which will bring greater growth momentum to China's pharmaceutical e-commerce, and the overall development of the industry is improving.

The overall scale of pharmaceutical e-commerce has expanded, and the B2B business has developed rapidly

With the state successively canceling the approval system for A, B and C certificates of Internet drugs and changing it to a regulatory system, China's pharmaceutical e-commerce has been further liberalized, which has promoted the growth of China's pharmaceutical e-commerce. According to the "Statistical Analysis Report on the Operation of the Pharmaceutical Circulation Industry" released by the Ministry of Commerce, according to incomplete statistics, in 2016, the total sales of China's pharmaceutical e-commerce were 61.2 billion yuan, and in 2017, the total sales of China's pharmaceutical e-commerce direct reporting enterprises reached 73.6 billion yuan (excluding A certificate), a year-on-year increase, accounting for the total scale of the national pharmaceutical market in the same period.

In 2018, China's pharmaceutical e-commerce A, B, and C certificates have been cancelled, and at the same time, the third-party pharmaceutical B2C model has developed rapidly, such as Meituan, etc., on the platform to open the pharmacy interface, pharmaceutical chain retail enterprises can access their own online stores to Meituan, expand operating income, and then promote the expansion of China's pharmaceutical e-commerce transaction scale. In 2018, affected by the change of the approval system to the regulatory system, under the relaxation of policies, the scale of pharmaceutical e-commerce transactions in China expanded rapidly, and the sales of pharmaceutical e-commerce direct reporting enterprises (excluding A certificates, that is, excluding third-party trading platforms) in 2018 were 97.8 billion yuan, a year-on-year increase; The total sales volume, including the transaction volume of the third-party transaction service platform, reached 231.5 billion yuan.

With the continuous advancement of medical reform, the prospect believes that in this round of medical reform, the separation of medicine and the optimization of the efficiency of the medical system will become one of the key points of policy promotion, and pharmaceutical e-commerce is expected to become an important tool for the regulator to achieve policy goals.

At the same time, the newly revised "Drug Administration Law" proposes to authorize the drug regulatory department to work with the competent health department and other departments to formulate specific measures for the management of online sales of drugs, and at the same time stipulates that several types of special management drugs cannot be sold online, leaving room for the exploration of Internet sales practice of prescription drugs.

There is no doubt that e-commerce is the trend of the future, but the most suitable for ordinary people to start a business is the B2C model.

The space is huge, according to statistics, the future market share of China's pharmaceutical e-commerce can reach hundreds of billions of yuan, and the total transaction volume of the current pharmaceutical e-commerce is less than 2 billion, I am a pharmaceutical B2B company (Baiou Pharmaceutical Network), I think it, in the current situation of relatively clear information, to intensively cultivate in the development, find their own model and development direction, to be more professional, must be infinitely bright!